AHR and pancreatic ductal adenocarcinoma: Activation of aryl hydrocarbon receptor (AhR) can promote TAMs from pancreatic ductal adenocarcinoma (PDAC) to immunosuppressive phenotype and inhibit the accumulation of CD8+ T cells in the tumor [111] (Figure 2a).